Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 100.33B | 95.90B | 91.57B | 86.29B | 85.81B |
Gross Profit | 25.34B | 24.58B | 22.78B | 21.80B | 22.86B |
EBITDA | 4.60B | 4.12B | 3.32B | 3.64B | 3.79B |
Net Income | 2.61B | 2.16B | 1.45B | 1.65B | 1.44B |
Balance Sheet | |||||
Total Assets | 50.74B | 51.18B | 48.69B | 46.32B | 43.19B |
Cash, Cash Equivalents and Short-Term Investments | 27.84B | 29.15B | 27.17B | 25.50B | 22.85B |
Total Debt | 9.80B | 10.62B | 11.27B | 10.84B | 8.46B |
Total Liabilities | 32.65B | 35.05B | 33.98B | 32.70B | 30.73B |
Stockholders Equity | 18.10B | 16.13B | 14.72B | 13.63B | 12.45B |
Cash Flow | |||||
Free Cash Flow | 558.42M | 3.22B | 1.32B | 685.22M | 954.80M |
Operating Cash Flow | 1.52B | 4.62B | 2.53B | 1.83B | 2.05B |
Investing Cash Flow | -1.38B | -1.23B | -1.03B | -1.27B | -1.02B |
Financing Cash Flow | -1.46B | -1.43B | -114.84M | 2.10B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥19.20B | 7.04 | 3.43% | 4.76% | 27.41% | ||
72 Outperform | ¥25.40B | 13.70 | 3.89% | -0.36% | -2.22% | ||
66 Neutral | ¥22.53B | 25.18 | 3.07% | 8.28% | 45.63% | ||
65 Neutral | ¥29.89B | 176.82 | 1.86% | 7.52% | -80.63% | ||
63 Neutral | ¥19.46B | 16.95 | 3.22% | 10.85% | 123.10% | ||
63 Neutral | $20.46B | 14.47 | -3.60% | 3.13% | 2.63% | -6.18% | |
― | ¥19.44B | 17.42 | 3.35% | ― | ― |
Human Holdings Co., Ltd. reported its consolidated financial results for the year ended March 31, 2025, showing a 4.6% increase in net sales and a notable 20.8% rise in profit attributable to owners of the parent. The company experienced a decrease in cash flows from operating activities, and its equity ratio improved to 35.7%. The announcement reflects a steady financial performance with a slight forecasted growth for the next fiscal year, indicating a stable market position.